牛叉诊股

[{"date":"2025.12.24","stock":"0.00","trade":"0.14","ind":"0.53"},{"date":"2025.12.23","stock":"-2.42","trade":"-1.13","ind":"0.07"},{"date":"2025.12.22","stock":"-1.68","trade":"-0.02","ind":"0.69"},{"date":"2025.12.19","stock":"2.73","trade":"1.30","ind":"0.36"},{"date":"2025.12.18","stock":"-1.56","trade":"0.74","ind":"0.16"},{"date":"2025.12.17","stock":"5.21","trade":"0.75","ind":"1.19"},{"date":"2025.12.16","stock":"-2.33","trade":"-1.92","ind":"-1.11"},{"date":"2025.12.15","stock":"-3.37","trade":"-0.38","ind":"-0.55"},{"date":"2025.12.12","stock":"-4.56","trade":"-0.79","ind":"0.41"},{"date":"2025.12.11","stock":"0.13","trade":"-1.22","ind":"-0.70"},{"date":"2025.12.10","stock":"-9.15","trade":"-0.11","ind":"-0.23"},{"date":"2025.12.09","stock":"-4.43","trade":"-1.56","ind":"-0.37"},{"date":"2025.12.08","stock":false,"trade":"-0.39","ind":"0.54"},{"date":"2025.12.05","stock":false,"trade":"-0.36","ind":"0.70"},{"date":"2025.12.04","stock":false,"trade":"-1.07","ind":"-0.06"},{"date":"2025.12.03","stock":false,"trade":"1.34","ind":"-0.51"},{"date":"2025.12.02","stock":false,"trade":"-0.75","ind":"-0.42"},{"date":"2025.12.01","stock":"6.72","trade":"1.06","ind":"0.65"},{"date":"2025.11.28","stock":"5.37","trade":"-0.86","ind":"0.34"},{"date":"2025.11.27","stock":"1.87","trade":"0.50","ind":"0.29"},{"date":"2025.11.26","stock":"-0.79","trade":"0.52","ind":"-0.15"}]

太龙药业,上证指数,中药指数

压力支撑

该股压力位为6.80元，支撑位为6.72元。

[{"text":"\u538b\u529b\u4f4d","value":"6.80","date":1766505600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"6.72","date":1766505600,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.2资金面打败了21%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：12月24日 20:30

机构今日流向(万元)	-352.54	机构5日流向(万元)	-1538.11
机构10日流向(万元)	-6062.46	机构20日流向(万元)	-20240.09

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量增加660.96万股，其中基金净增仓2家，主力净增仓5家，有一定的中长期投资价值。

截止2025-06-30，共42家主力机构（基金38家，一般法人3家，QFII1家），持仓量总计15000.32万股，占流通A股26.14%
其中，基金持仓与2024-12-31相比：
增仓：8家，增持 38.49万股
减仓：6家，减持 8.61万股
新出现在主力名单中：24家，持有772.27万股
从主力名单中消失：19家，原持有141.19万股

消息面诊股

诊断结果：6消息面打败了97%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

利好	股票增发	董事会通过	2025-12-09
一般消息	资产重组	公司股权转让	2025-12-09
一般消息	重大事项	关联交易	2025-12-09
一般消息	募资投向	公司购买资产	2025-11-12
一般消息	重大事项	关联交易	2025-11-12
一般消息	股东大会	临时股东大会	2025-10-30
利好	分红转增	10派0.14元(含税)	2025-10-30
一般消息	重大事项	公司股东股份冻结	2025-10-17
一般消息	重大事项	关联交易	2025-09-27
一般消息	重大事项	关联交易	2025-09-20
一般消息	分红转增	不分配不转增	2025-08-27
一般消息	高管变动	取消监事会	2025-08-15
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-06-30
一般消息	分红转增	不分配不转增	2025-04-09
一般消息	重大事项	关联交易	2025-04-09
利好	重大事项	参股拟上市公司或非上市公司金融机构	2024-12-31

一年消息统计

	所有消息	重大消息	非重大消息
利好	4条	0条	4条
利空	0条	0条	0条

行业面诊股

诊断结果：5.3行业面打败了71%的股票中药行业最新资金流向

近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑输大盘。

[{"date":"2025.12.24","price":"0.53","value":"0.14"},{"date":"2025.12.23","price":"0.07","value":"-1.13"},{"date":"2025.12.22","price":"0.69","value":"-0.02"},{"date":"2025.12.19","price":"0.36","value":"1.30"},{"date":"2025.12.18","price":"0.16","value":"0.74"},{"date":"2025.12.17","price":"1.19","value":"0.75"},{"date":"2025.12.16","price":"-1.11","value":"-1.92"},{"date":"2025.12.15","price":"-0.55","value":"-0.38"},{"date":"2025.12.12","price":"0.41","value":"-0.79"},{"date":"2025.12.11","price":"-0.70","value":"-1.22"},{"date":"2025.12.10","price":"-0.23","value":"-0.11"},{"date":"2025.12.09","price":"-0.37","value":"-1.56"},{"date":"2025.12.08","price":"0.54","value":"-0.39"},{"date":"2025.12.05","price":"0.70","value":"-0.36"},{"date":"2025.12.04","price":"-0.06","value":"-1.07"},{"date":"2025.12.03","price":"-0.51","value":"1.34"},{"date":"2025.12.02","price":"-0.42","value":"-0.75"},{"date":"2025.12.01","price":"0.65","value":"1.06"},{"date":"2025.11.28","price":"0.34","value":"-0.86"},{"date":"2025.11.27","price":"0.29","value":"0.50"},{"date":"2025.11.26","price":"-0.15","value":"0.52"}]

上证指数,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	江中药业	12.56%	0.57%	6.5分
2	马应龙	4.10%	-2.12%	6.1分
3	东阿阿胶	3.70%	0.78%	6.2分
4	吉林敖东	3.21%	1.03%	5.6分
5	达仁堂	1.90%	0.26%	6.1分
6	佛慈制药	1.79%	7.45%	5.2分
7	天目药业	1.24%	0.35%	6.1分
8	云南白药	0.93%	0.53%	6.5分
9	济川药业	0.72%	-1.38%	5.0分
10	亚宝药业	0.30%	1.84%	5.1分
11	华润三九	0.24%	1.52%	6.4分
12	方盛制药	0.00%	2.97%	5.6分
13	白云山	-0.31%	0.66%	5.8分
14	佐力药业	-0.53%	-0.29%	4.4分
15	沃华医药	-1.28%	4.93%	5.7分
16	三力制药	-1.33%	1.20%	5.0分
17	-	-1.37%	0.11%	分
18	益佰制药	-1.42%	2.71%	6.2分
19	葵花药业	-1.52%	-1.58%	4.5分
20	天士力	-1.55%	1.13%	5.6分
21	嘉应制药	-2.54%	-1.62%	5.3分
22	汉森制药	-2.61%	3.87%	4.9分
23	ST香雪	-2.66%	5.08%	4.2分
24	奇正藏药	-2.67%	0.37%	4.5分
25	古汉医药	-2.79%	3.82%	4.9分
26	寿仙谷	-2.98%	0.77%	4.8分
27	康恩贝	-2.99%	-1.09%	5.4分
28	康惠股份	-3.26%	0.48%	4.3分
29	片仔癀	-3.36%	-0.86%	5.1分
30	益盛药业	-3.48%	2.91%	4.2分
31	仁和药业	-3.50%	0.17%	5.0分
32	维康药业	-3.54%	20.12%	5.8分
33	步长制药	-3.68%	1.60%	5.5分
34	桂林三金	-3.94%	1.11%	5.6分
35	红日药业	-4.00%	0.56%	4.8分
36	千金药业	-4.18%	0.58%	5.5分
37	中恒集团	-4.41%	1.81%	5.3分
38	上海凯宝	-4.52%	1.16%	4.7分
39	新光药业	-4.66%	1.12%	4.8分
40	太龙药业	-4.72%	-2.97%	4.6分
41	-	-4.89%	1.34%	分
42	康美药业	-4.93%	0.52%	5.4分
43	羚锐制药	-4.97%	0.29%	5.4分
44	珍宝岛	-5.14%	0.31%	4.9分
45	同仁堂	-5.28%	-2.46%	4.4分
46	九芝堂	-5.49%	1.36%	5.4分
47	太极集团	-5.54%	3.52%	5.1分
48	广誉远	-5.58%	2.50%	5.5分
49	昆药集团	-5.60%	0.48%	5.1分
50	华神科技	-5.71%	2.06%	4.5分
51	ST葫芦娃	-5.97%	3.16%	4.3分
52	健民集团	-6.27%	0.94%	5.1分
53	新天药业	-6.51%	3.07%	5.1分
54	万邦德	-6.66%	2.69%	5.2分
55	陇神戎发	-7.35%	1.57%	4.7分
56	康缘药业	-7.50%	0.07%	4.3分
57	恩威医药	-8.18%	1.71%	5.2分
58	华森制药	-8.22%	0.40%	4.8分
59	精华制药	-8.45%	1.10%	5.1分
60	盘龙药业	-9.56%	0.76%	4.6分
61	以岭药业	-9.70%	-0.63%	5.3分
62	粤万年青	-9.79%	-0.65%	4.0分
63	金花股份	-10.79%	1.17%	5.0分
64	ST百灵	-11.19%	-2.50%	4.6分
65	振东制药	-11.52%	-1.32%	4.5分
66	信邦制药	-14.06%	1.23%	4.8分
67	特一药业	-18.44%	-1.68%	4.8分
68	众生药业	-23.72%	-1.52%	4.5分
69	*ST长药	-41.77%	-9.94%	3.6分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：5.1基本面打败了20%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（30分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 49/109 ， 62/109。

[{"date":"2025-09-30","value":"1.60","vol":"4.74"},{"date":"2025-06-30","value":"1.22","vol":"3.98"},{"date":"2025-03-31","value":"0.10","vol":"2.21"},{"date":"2024-12-31","value":"3.20","vol":"4.80"},{"date":"2024-09-30","value":"1.84","vol":"2.91"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	1.60	1.22	0.10	3.20	1.84
行业(%)	4.74	3.98	2.21	4.80	2.91

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"24.29","vol":"52.31"},{"date":"2025-06-30","value":"24.69","vol":"52.86"},{"date":"2025-03-31","value":"26.81","vol":"53.38"},{"date":"2024-12-31","value":"25.59","vol":"52.74"},{"date":"2024-09-30","value":"26.49","vol":"53.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	24.29	24.69	26.81	25.59	26.49
行业(%)	52.31	52.86	53.38	52.74	53.11

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 44/109 ， 40/109。

[{"date":"2025-09-30","value":"-11.47","vol":"-7.31"},{"date":"2025-06-30","value":"-17.77","vol":"-7.31"},{"date":"2025-03-31","value":"-35.23","vol":"-7.18"},{"date":"2024-12-31","value":"-6.21","vol":"-7.35"},{"date":"2024-09-30","value":"-7.08","vol":"-5.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-11.47	-17.77	-35.23	-6.21	-7.08
行业(%)	-7.31	-7.31	-7.18	-7.35	-5.11

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"-12.36","vol":"-2.54"},{"date":"2025-06-30","value":"-27.32","vol":"2.98"},{"date":"2025-03-31","value":"-92.80","vol":"-37.19"},{"date":"2024-12-31","value":"16.00","vol":"-146.29"},{"date":"2024-09-30","value":"270.72","vol":"61.78"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	-12.36	-27.32	-92.80	16.00	270.72
行业(%)	-2.54	2.98	-37.19	-146.29	61.78

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 37/109 ， 16/109。

[{"date":"2025-09-30","value":"0.33","vol":"0.35"},{"date":"2025-06-30","value":"0.22","vol":"0.24"},{"date":"2025-03-31","value":"0.09","vol":"0.12"},{"date":"2024-12-31","value":"0.55","vol":"0.50"},{"date":"2024-09-30","value":"0.37","vol":"0.37"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.33	0.22	0.09	0.55	0.37
行业(次)	0.35	0.24	0.12	0.50	0.37

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"2.12","vol":"1.73"},{"date":"2025-06-30","value":"1.36","vol":"1.18"},{"date":"2025-03-31","value":"0.65","vol":"0.61"},{"date":"2024-12-31","value":"3.51","vol":"2.42"},{"date":"2024-09-30","value":"2.02","vol":"1.81"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	2.12	1.36	0.65	3.51	2.02
行业(次)	1.73	1.18	0.61	2.42	1.81

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"5.35","vol":"9.48"},{"date":"2025-06-30","value":"-27.92","vol":"20.05"},{"date":"2025-03-31","value":"3.39","vol":"-0.23"},{"date":"2024-12-31","value":"9.51","vol":"15.64"},{"date":"2024-09-30","value":"-1.15","vol":"5.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	5.35	-27.92	3.39	9.51	-1.15
行业	9.48	20.05	-0.23	15.64	5.86

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.18","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.51","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	0.18	-	0.51	-
行业	0.00	1.02	0.00	1.45	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 30/109 ， 11/109。

[{"date":"2025-09-30","value":"1.16","vol":"3.05"},{"date":"2025-06-30","value":"1.29","vol":"2.90"},{"date":"2025-03-31","value":"1.13","vol":"2.99"},{"date":"2024-12-31","value":"1.06","vol":"2.88"},{"date":"2024-09-30","value":"1.07","vol":"3.25"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	1.16	1.29	1.13	1.06	1.07
行业	3.05	2.90	2.99	2.88	3.25

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.84","vol":"2.21"},{"date":"2025-06-30","value":"0.91","vol":"2.13"},{"date":"2025-03-31","value":"0.86","vol":"2.22"},{"date":"2024-12-31","value":"0.80","vol":"2.11"},{"date":"2024-09-30","value":"0.75","vol":"2.43"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	0.84	0.91	0.86	0.80	0.75
行业	2.21	2.13	2.22	2.11	2.43

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 7/109 ， 6/109。

[{"date":"2025-09-30","value":"55.88","vol":"33.12"},{"date":"2025-06-30","value":"53.76","vol":"33.87"},{"date":"2025-03-31","value":"54.26","vol":"33.29"},{"date":"2024-12-31","value":"53.40","vol":"34.05"},{"date":"2024-09-30","value":"56.51","vol":"32.87"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	55.88	53.76	54.26	53.40	56.51
行业(%)	33.12	33.87	33.29	34.05	32.87

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.31","vol":"0.75"},{"date":"2025-06-30","value":"1.20","vol":"0.74"},{"date":"2025-03-31","value":"1.23","vol":"0.72"},{"date":"2024-12-31","value":"1.18","vol":"0.75"},{"date":"2024-09-30","value":"1.34","vol":"3.20"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	1.31	1.20	1.23	1.18	1.34
行业(%)	0.75	0.74	0.72	0.75	3.20

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2025年的收益，请投资者后续关注。

[{"date":"2021","yellowRectValue":"0.06","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-0.72","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.44","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.51","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[太龙药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]